Thermo Fisher Scientific Inc’s recently made public that its Chairman & CEO CASPER MARC N unloaded Company’s shares for reported $5.17 million on Mar 04 ’25. In the deal valued at $516.67 per share,10,000 shares were sold. As a result of this transaction, CASPER MARC N now holds 115,174 shares worth roughly $61.24 million.
Then, CASPER MARC N sold 8,000 shares, generating $4,160,144 in total proceeds. Upon selling the shares at $520.02, the Chairman & CEO now owns 115,174 shares.
Before that, CASPER MARC N bought 8,000 shares. Thermo Fisher Scientific Inc shares valued at $4,160,151 were divested by the Officer at a price of $520.02 per share.
Bernstein upgraded its Thermo Fisher Scientific Inc [TMO] rating to an Outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in late December with a ‘”a Sector perform”‘ rating. Redburn Atlantic began covering TMO with “Buy” recommendation on October 14, 2024. Stephens started covering the stock on October 01, 2024. It rated TMO as “an Overweight”.
Price Performance Review of TMO
On Friday, Thermo Fisher Scientific Inc [NYSE:TMO] saw its stock jump 0.77% to $531.71. Over the last five days, the stock has gained 0.52%. Thermo Fisher Scientific Inc shares have risen nearly 2.21% since the year began. Nevertheless, the stocks have fallen -9.05% over the past one year. While a 52-week high of $627.88 was reached on 01/30/25, a 52-week low of $493.30 was recorded on 03/05/25. SMA at 50 days reached $548.09, while 200 days put it at $566.71.
Levels Of Support And Resistance For TMO Stock
The 24-hour chart illustrates a support level at 523.02, which if violated will result in even more drops to 514.32. On the upside, there is a resistance level at 536.69. A further resistance level may holdings at 541.67. The Relative Strength Index (RSI) on the 14-day chart is 45.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 38.30%. Stochastics %K at 49.51% indicates the stock is a holding.
The most recent change occurred on August 28, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $670 price target.
